232 results on '"Lynn, Rachel"'
Search Results
2. Tuning the Antigen Density Requirement for CAR T-cell Activity
3. Dynamic chromatin regulatory landscape of human CAR T cell exhaustion
4. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
5. Specialization of integral closure of ideals by general elements.
6. CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy
7. Planning for Connected, Autonomous and Shared Mobility: A Synopsis of Practitioners’ Perspectives
8. 278 Preclinical development of LYL119, a ROR1-targeted CAR T-cell product incorporating four novel T-cell reprogramming technologies to overcome barriers to effective cell therapy for solid tumors
9. Specialization of integral closure of ideals by general elements
10. Redgrave, Lynn Rachel, (8 March 1943–2 May 2010), actress
11. c-Jun overexpression in CAR T cells induces exhaustion resistance
12. Defining ‘T cell exhaustion’
13. The role of her-targeted therapies on chemosensization in gastro-oesphageal cancer cells
14. Supplementary Data from Tuning the Antigen Density Requirement for CAR T-cell Activity
15. Data from Tuning the Antigen Density Requirement for CAR T-cell Activity
16. Supplementary Figure 2 from A Universal Strategy for Adoptive Immunotherapy of Cancer through Use of a Novel T-cell Antigen Receptor
17. Supplementary Figure 3 from A Universal Strategy for Adoptive Immunotherapy of Cancer through Use of a Novel T-cell Antigen Receptor
18. Supplementary Figure 1 from A Universal Strategy for Adoptive Immunotherapy of Cancer through Use of a Novel T-cell Antigen Receptor
19. Data from A Universal Strategy for Adoptive Immunotherapy of Cancer through Use of a Novel T-cell Antigen Receptor
20. Supplementary Figure Legends 1-3 from A Universal Strategy for Adoptive Immunotherapy of Cancer through Use of a Novel T-cell Antigen Receptor
21. ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids
22. Psychiatric Emergencies
23. Targeting of folate receptor β on acute myeloid leukemia blasts with chimeric antigen receptor–expressing T cells
24. 232 Increased potency and functional persistencein vitroof a next-generation NY-ESO-1-specific TCR therapy incorporating Gen-R™ genetic reprogramming technology
25. 243 NR4A3 gene editing and c-Jun overexpression synergize to limit exhaustion and enhance functional activity of ROR1 CAR T cellsin vitroandin vivo
26. Abstract 2754: LYL797, a ROR1 CAR T-cell therapy with genetic and epigenetic reprogramming for solid tumors
27. Reconceptualizing Design-Build for More Efficient Budgeting and Scheduling
28. Specialization and Complexity of Integral Closure of Ideals
29. Dynamic chromatin regulatory landscape of human CAR T cell exhaustion
30. Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling
31. Strength in Numbers: Identifying Neoantigen Targets for Cancer Immunotherapy
32. What Do I Say? Suicide Assessment and Management
33. Transient “rest” induces functional reinvigoration and epigenetic remodeling in exhausted CAR-T cells
34. c-Jun Overexpressing CAR-T Cells are Exhaustion-Resistant and Mediate Enhanced Antitumor Activity
35. Pharmacologic control of CAR-T cell function using dasatinib
36. Regulation of chemotropic guidance of nerve growth cones by microRNA
37. Low CD19 Antigen Density Diminishes Efficacy of CD19 CAR T Cells and Can be Overcome By Rational Redesign of CAR Signaling Domains
38. Abstract LB-111: Precise regulation of CAR signaling prevents and reverses CAR T cell exhaustion
39. Abstract LB-112: Engineering AP1 to combat CAR T cell exhaustion
40. Neurotoxicity Associated with a High-Affinity GD2 CAR—Letter
41. Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccines
42. Targeting FRβ+ tumor associated macrophages with car T cells in ovarian cancer
43. Strain-dependent Lethal Toxicity in NKG2D Ligand-targeted CAR T-cell Therapy
44. Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor
45. 285. Exploring On-Target Hematopoietic Toxicity With Highly Potent, High Affinity FRβ-Specific CAR T Cells for AML
46. Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells
47. Carnal Knowledge.
48. Tissue Exit: a Novel Control Point in the Accumulation of Antigen-Specific CD8 T Cells in the Influenza A Virus-Infected Lung
49. Tissue exit - a novel control point in the accumulation of antigen-specific CD8 T cells in the influenza A virus-infected lung (173.20)
50. Treating Tumors With a Vaccinia Virus Expressing IFNβ Illustrates the Complex Relationships Between Oncolytic Ability and Immunogenicity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.